Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: Is it likely to be superior?

European Archives of Oto-Rhino-Laryngology

Volumn 261, Issue 9, 2004, Pages 479-483

  Brouwer, Jolijn ^a   De Bree, Remco ^a   Comans, Emile F I ^a   Castelijns, Jonas A ^a   Hoekstra, Otto S ^a   Leemans, C René ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F fluorodeoxyglucose; Clinically negative neck; Head and neck cancer; Occult lymph node metastases; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 8644250424     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-003-0727-3     Document Type: Article

References (30)

1. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA (1982) Prognostic factors of neck node metastases. Clin Otolaryngol 7:182-192
2. Leemans CR, Tiwari R, Nauta JJ, Van der Waal I, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck cancer. Cancer 71:452-456
3. Ali S, Tiwari RM, Snow GB (1985) False positive and false negative neck nodes. Head Neck Surg 8:78-82
4. Van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB (1993) Modern imaging techniques and ultrasound guided aspiration cytology for the assessment of the neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 250:11-17
5. Nieuwenhuis EJ, Castelijns JA, Pijpers R, Van den Brekel MW, Brakenhoff RH, Van der Waal I, Snow GB, Leemans CR (2002) Wait-and-see policy for the NO neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 24:282-289
6. Braams JW, Pruim J, Freling NJM, Nikkels PGJ, Nikkels PGJ, Roodenburg JLN, Boering G, Vaalburg W, Vermey A (1995) Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36:211-216
7. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W (1999) Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 125:1322-1332
8. 18F-FDG PET with conventional imaging modalities (CT,MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255-1260
9. Sobin LH, Wittekind Ch (eds) (1997) TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York
10. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, Wolf GT; American Head and Neck Society; American Academy of Otolaryngology and Head and Neck Surgery (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology and Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751-758
11. Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D (1998) Positron emission tomography in the evaluation of the NO neck. Laryngoscope 108:232-236
12. Myers LL, Wax MK (1998) Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 27:342-347
13. Hyde NC, Prvulovich E, Newman L, Waddington WA, Visvikis D, Ell P (2003) A new approach to pretreatment assessment of the NO neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39:350-360
14. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S (2003) Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24:345-349
15. Civantos FJ, Gomez C, Duque C, Pedroso F, Goodwin WJ, Weed DT, Arnold D, Moffat F (2003) Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry Head Neck 25:1-9
16. Van den Brekel MW, Van der Waal I, Meijer CJ, Freeman JL, Castelijns JA, Snow GB (1996) The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106:987-991
17. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S (2002) Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 112:111-115
18. Van den Brekel MWM, Castelijns JA, Snow GB (1998) Diagnostic evaluation of the neck. Otolaryngol Clin N Am 31: 609-619
19. Hollenbeak CS, Lowe VJ, Stack BC (2001) The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck. Cancer 92:2341-2348
20. Mijnhout GS, Hoekstra OS, van Lingen A, van Diest PJ, Ader HJ, Lammertsma AA, Pijpers R, Meijer S, Teule GJ (2003) How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma. J Clin Pathol 56:283-286
21. Pieterman RM, Putten JWG van, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJM (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography New Engl J Med 343:254-261
22. Stuckensen T, Kovacs AF, Adams S, Baum RP (2000) Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28:319-324
23. Brink I, Klenzer Th, Krause Th, Mix M, Ross UH, Moser E, Nitzsche EU (2002) Lymph node staging in extracranialhead and neck cancer with FDG PET - appropriate uptake period and size dependence of the results. Nuklearmedizin 41:108-113
24. Hamakawa H, Tekemura K, Sumida T, Kayahara H, Tanioka H, Sogawa K (2000) Histological study on pN upgrading of oral cancer. Virchows Arch 437:116-121
25. Torrenga H, Licht J, Van der Hoeven JJM, Hoekstra OS, Meijer S, Van Diest PJ (2001) Re: axillary lymph node staging by 2-fluoro-2-deoxy-D-glucose- positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 93:1659-1660
26. Baum RP, Adams S, Kiefer J, Niesen A, Knecht R, Howaldt HP, Hertel A, Adamietz IA, Sykes T, Boniface GR (1993) A novel technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 32:747-751
27. 2. J Nucl Med 35:775-783
28. 99mTc-labeled monoclonal antibody U36 and its biodistribution in patients with head and neck cancer. Clin Cancer Res 1:591-598
29. Meijs WE, Haisma HJ, Klok RP, van Gog FB, Kievit E, Pinedo HM, Herscheid JD (1997) Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice. J Nucl Med 38:112-118
30. Verel, GWM Visser, R Boellaard, M Stigter-van Walsum, GB Snow, GAMS van Dongen (2003) Zirconium-89 immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. J Nucl Med (in press)